Showing 1 - 5 results of 5 for search 'Yaron Carmi', query time: 0.03s Refine Results
  1. 1
    Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations

    Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations by Peleg Rider, Yaron Carmi, Idan Cohen

    Published 2016-01-01
    Get full text
    Article
  2. 2
    Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity

    Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity by Leen Farhat-Younis, Manho Na, Amichai Zarfin, Aseel Khateeb, Nadine Santana-Magal, Alon Richter, Amit Gutwillig, Diana Rasoulouniriana, Annette Gleiberman, Lir Beck, Tamar Giger, Avraham Ashkenazi, Adi Barzel, Peleg Rider, Yaron Carmi

    Published 2024-06-01
    Get full text
    Article
  3. 3
    Correction: Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity

    Correction: Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity by Leen Farhat-Younis, Manho Na, Amichai Zarfin, Aseel Khateeb, Nadine Santana-Magal, Alon Richter, Amit Gutwillig, Diana Rasoulouniriana, Annette Gleiberman, Lir Beck, Tamar Giger, Avraham Ashkenazi, Adi Barzel, Peleg Rider, Yaron Carmi

    Published 2024-07-01
    Get full text
    Article
  4. 4
    Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy

    Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy by Avishai Maliah, Nadine Santana-Magal, Shivang Parikh, Sagi Gordon, Keren Reshef, Yuval Sade, Aseel Khateeb, Alon Richter, Amit Gutwillig, Roma Parikh, Tamar Golan, Matan Krissi, Manho Na, Gal Binshtok, Paulee Manich, Nadav Elkoshi, Sharon Grisaru-Tal, Valentina Zemser-Werner, Ronen Brenner, Hananya Vaknine, Eran Nizri, Lilach Moyal, Iris Amitay-Laish, Luiza Rosemberg, Ariel Munitz, Noga Kronfeld-Schor, Eric Shifrut, Oren Kobiler, Asaf Madi, Tamar Geiger, Yaron Carmi, Carmit Levy

    Published 2024-09-01
    Get full text
    Article
  5. 5
    MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

    MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer by Barak Rotblat, Andreas Mock, Jerome Fayette, Limor Cohen, Idan Cohen, Elena Voronov, Jebrane Bouaoud, Lucas Michon, Pierre Saintigny, Luc G T Morris, Manu Prasad, Jonathan Zorea, Sankar Jagadeeshan, Avital B Shnerb, Sooraj Mathukkada, Ofra Novoplansky, Mai Badarni, Ksenia M Yegodayev, Sapir Tzadok, Libor Brezina, Andy Karabajakian, Tomer Cooks, Irit Allon, Orr Dimitstein, Benzion Joshua, Dexin Kong, Maurizio Scaltriti, Yaron Carmi, Cristina Conde-Lopez, Jochen Hess, Ina Kurth, Moshe Elkabets

    Published 2022-03-01
    Get full text
    Article

Search Tools: